Ridley-Merriweather Katherine E, Okoruwa Oseme Precious, Vogel Katherine
IU Simon Comprehensive Cancer Center, 550 University Blvd., AOC Room 6042, Indianapolis, IN, 46202, USA.
Indiana University School of Medicine, 340 W. 10th St., Indianapolis, IN, 46202, USA.
Contemp Clin Trials Commun. 2024 Nov 25;42:101403. doi: 10.1016/j.conctc.2024.101403. eCollection 2024 Dec.
The presence of strong barriers to research participation for Black women is indisputable. However, existing evidence supports the possibility of equal levels of participation among members of minoritized populations in past breast cancer (BC) clinical trials (CTs), demonstrating that while these participation barriers undoubtedly exist but are not insurmountable. This work aims to investigate patient-provider conversations to try to illuminate how providers can better engage Black women in communication that will positively influence their perceptions of breast cancer clinical trial participation. Fourteen women (N = 14) who self-identified as Black, Black American, or African American and who had previously or were currently involved in a BC CT participated in the grounded theory-guided study. These women were recruited through emails and social media platforms and interviewed regarding their communication with their medical providers and their pathway to CT participation. Findings revealed three primary categories: 1) participants reported the following provider types as most effective communicators: attentive, matter-of-fact, warm, or above-and beyond; 2) participants frequently received no information about CTs from their providers; and 3) cultural constructs including faith, word of mouth, and storytelling are important to the recruitment of these Black women to BC CTs. Our findings demonstrate the importance of healthcare providers adjusting their communication to meet one of the preferred provider archetypes of communication styles, understanding and incorporating cultural constructs in their communication, and providing information about BC CTs to Black women. Through improved patient-provider communication, healthcare providers may positively influence Black women's perceptions of and participation in BC CTs.
黑人女性参与研究存在强大障碍,这是无可争议的。然而,现有证据支持在过去的乳腺癌(BC)临床试验(CT)中,少数族裔群体成员有平等参与水平的可能性,这表明虽然这些参与障碍无疑存在,但并非无法克服。这项工作旨在调查患者与医疗服务提供者之间的对话,试图阐明医疗服务提供者如何更好地让黑人女性参与到能积极影响她们对乳腺癌临床试验参与看法的沟通中。14名自我认定为黑人、非裔美国人或美国黑人且曾参与或正在参与乳腺癌CT的女性参与了这项基于扎根理论的研究。这些女性通过电子邮件和社交媒体平台招募,并就她们与医疗服务提供者的沟通以及参与CT的途径接受了访谈。研究结果揭示了三个主要类别:1)参与者报告以下类型的医疗服务提供者是最有效的沟通者:专注、实事求是的、热情的或超乎寻常的;2)参与者经常从医疗服务提供者那里得不到关于CT的任何信息;3)包括信仰、口碑和讲故事在内的文化建构对于招募这些黑人女性参与乳腺癌CT很重要。我们的研究结果表明,医疗服务提供者调整沟通方式以符合首选的沟通风格原型之一、在沟通中理解并纳入文化建构以及向黑人女性提供关于乳腺癌CT的信息非常重要。通过改善患者与医疗服务提供者之间沟通,医疗服务提供者可能会积极影响黑人女性对乳腺癌CT的看法和参与度。